Buy-rated reports

573 tickers rated Buy
Ranks this page's recent reports by score.
argenx SE
ARGX·Healthcare
A ★★★★Buy
Current$873.71
Target$1,064.00
Return+21.8%
Oct 25, 2026

argenx combines rapidly growing VYVGART sales with a promising multi-indication immunology pipeline and strong profitability, although product concentration, clinical setbacks, and demanding growth expectations create meaningful downside risk.

Score
79
Allegion plc
ALLE·Industrials
A ★★★★Buy
Current$178.98
Target$191.52
Return+7.0%
Oct 25, 2026

Allegion combines durable security-hardware brands, strong cash generation, and expanding electronic-access opportunities, although its valuation and exposure to commercial construction limit the margin of safety.

Score
84
Alcoa Corporation
AA·Materials
A ★★★★Buy
Current$37.91
Target$46.89
Return+23.7%
Oct 25, 2026

Alcoa offers discounted exposure to improving aluminum production efficiency and potential acquisition synergies, but commodity-price volatility and debt-financed expansion create meaningful risks to sustainable earnings.

Score
78
First Citizens BancShares, Inc.
FCNCA·Financials
A ★★★★Buy
Current$2,375.84
Target$2,500.00
Return+5.2%
Oct 25, 2026

First Citizens combines specialized commercial banking, strong capital returns, and improving funding flexibility, but deposit repricing pressure and concentrated credit exposure could constrain sustainable earnings growth.

Score
76
Northrop Grumman Corporation
NOC·Industrials
A ★★★★Buy
Current$551.44
Target$600.60
Return+8.9%
Oct 25, 2026

Northrop Grumman combines a formidable defense-technology moat, record backlog, and attractive historical cash-flow valuation, but B-21 cost exposure and capital-intensive production expansion could constrain future returns.

Score
82
WD-40 Company
WDFC·Materials
A ★★★★Buy
Current$212.71
Target$222.70
Return+4.7%
Oct 24, 2026

WD-40 combines an iconic global maintenance brand, exceptional capital efficiency, and durable cash generation with international growth opportunities, although elevated earnings multiples and input-cost pressure constrain near-term upside.

Score
82
Kaiser Aluminum Corporation
KALU·Materials
A ★★★★Buy
Current$107.06
Target$126.00
Return+17.7%
Oct 24, 2026

Kaiser Aluminum offers value through aerospace specialization, recovering cash generation, and improved leverage after a severe share-price correction, but recurring manufacturing inefficiencies and cyclical earnings remain significant risks.

Score
77
Primerica, Inc.
PRI·Financials
A ★★★★Buy
Current$274.49
Target$323.04
Return+17.7%
Oct 24, 2026

Primerica combines a profitable insurance franchise, growing investment-product earnings, and disciplined buybacks at an attractive valuation, although declining policy production threatens sustainable organic growth.

Score
81
Fidelity National Financial, Inc.
FNF·Financials
A ★★★★Buy
Current$40.44
Target$50.00
Return+23.6%
Oct 24, 2026

Fidelity National Financial combines dominant title insurance operations, improving margins, and an attractive dividend with recovery upside, although mortgage-market cyclicality and F&G insurance risks could delay earnings growth.

Score
79
Nasdaq, Inc.
NDAQ·Financials
A ★★★★Buy
Current$102.56
Target$112.56
Return+9.7%
Oct 24, 2026

Nasdaq combines durable exchange network effects with fast-growing financial technology and index licensing revenue, creating a compelling long-term compounder, although acquisition-related debt and demanding cash-flow multiples constrain upside.

Score
83
Stifel Financial Corp.
SF·Financials
A ★★★★Buy
Current$66.68
Target$84.00
Return+26.0%
Oct 24, 2026

Stifel combines recurring wealth management income, improving returns on capital, and an attractive forward earnings valuation, although expanding credit exposure and cyclical investment banking activity create meaningful downside risks.

Score
77
SEI Investments Company
SEIC·Financials
A ★★★★Buy
Current$102.30
Target$117.00
Return+14.4%
Oct 24, 2026

SEI combines sticky financial-services infrastructure, high returns on capital, and substantial buybacks to compound per-share earnings, although elevated historical valuation and asset-market sensitivity limit the margin of safety.

Score
79